Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells

Expression of Hypoxia Inducible Factor-1α and Its Significance in Laryngeal Carcinoma

(2013) X-H Wu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II

(2012) Can Huang et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression

(2011) Ling-Zhi Liu et al.   PLoS One

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

(2010) Y. Li et al.   CURRENT CANCER DRUG TARGETS

Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinoma

(2010) Erdenebulgan Batmunkh et al.   International Journal of Clinical Oncology

Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells

(2010) Zhenyu Ding et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia

(2010) Shi-Young Park et al.   JOURNAL OF PINEAL RESEARCH

MDR1/P-gp and VEGF Synergistically Enhance the Invasion of Hep-2 Cells with Multidrug Resistance Induced by Taxol

(2009) Li Li et al.   ANNALS OF SURGICAL ONCOLOGY

Evaluation of the revised TNM classification in advanced laryngeal cancer

(2009) G. Psychogios et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer

(2009) R. Cabanillas et al.   JOURNAL OF SURGICAL ONCOLOGY

Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1α up-regulation and MMP9 activation

(2008) Gang Song et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE